In vitro activity of 10 cephalosporins and imipenem to 65 methicillin sensitive staphylococci
Jerris, R.; Anderson, N.; Gomez, N.; Parkinson, N.
Abstracts of the General Meeting of the American Society for Microbiology 91: 381
1991
ISSN/ISBN: 1060-2011 Accession: 031854462
PDF emailed within 1 workday: $29.90
Related References
Laverdiere, M.; Peterson, P.; Verhoef, J.; Williams, D.N.; Sabath, L.D. 1978: In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci Journal of Infectious Diseases 137(3): 245-250Sachdeva, M.; Hackbarth, C.; Stella, F.B.; Chambers, H.F. 1987: Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci Antimicrobial Agents and ChemoTherapy 31(10): 1549-1552
John, J.F.; McNeill, W.F. 1980: Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase Antimicrobial Agents and ChemoTherapy 17(2): 179-183
Tome, G.; Casellas, J.M.; Rolon, M.J.; Lopez Furst, M.J. 1999: In vitro activity of combinations of arbekacin with trovafloxacin , vancomycin , imipenem or ciprofloxacin against isolates recovered from severe mixed infections including methicillin resistant staphylococci Journal of Antimicrobial ChemoTherapy 44(Suppl A): 138
Hara, T.; Araake, M.; Tsuruoka, T.; Watabe, H. 2003: Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci Japanese Journal of Antibiotics 56(2): 142-147
Mouton, R.P.; Lampe, A.S.; van Maanen, D.B.; van der Reijden, T.J. 1984: Activity of cephalosporins against methicillin-resistant coagulase-negative staphylococci European Journal of Clinical Microbiology 3(2): 144-146
Varaldo, P.E.; Debbia, E.; Schito, G.C. 1984: In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci Journal of Antimicrobial ChemoTherapy 14 Suppl D: 35-41
Forbes, B.A.; McClatchey, K.D.; Schaberg, D.R. 1984: Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus Antimicrobial Agents and ChemoTherapy 25(4): 491-493
Libert, J.M.; Colas des Francs, D. 1985: Sensitivity to cephalosporins of coagulase-negative methicillin-resistant staphylococci. in vitro studies by different methods Pathologie-Biologie 33(8): 831-835
Uete, T.; Matsuo, K. 1995: Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus Japanese Journal of Antibiotics 48(3): 402-408
Cokça, F.üg.; Arman, D.; Altay, G.ül. 1998: In vitro activity of vancomycin combined with rifampin, amikacin, ciprofloxacin or imipenem against methicillin-resistant and methicillin-susceptible Staphylococcus aureus Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 4(11): 657-659
Shah, P.M.; Knothe, H. 1991: The in vitro activity of flomoxef compared to four other cephalosporins and imipenem Infection 19(Suppl): S279-S283
Gahrn-Hansen, B.; Søgaard, P.; Arpi, M. 1987: In vitro activity of ciprofloxacin against methicillin-susceptible and methicillin-resistant staphylococci European Journal of Clinical Microbiology 6(5): 581-584
Vurma-Rapp, U.; Kayser, F.H.; Barberis-Maino, L. 1986: Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa Journal of Antimicrobial ChemoTherapy 18 Suppl E: 27-33
Schumacher-Perdreau, F.; Jansen, B.; Peters, G. 1991: In vitro activity of cefpodoxime against staphylococci in comparison to other cephalosporins European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 10(7): 585-588